Evidence map›Paper›PMID 26136432›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Prenatal Allospecific NK Cell Tolerance Hinges on Instructive Allorecognition through the Activating Receptor during Development.

Amir M Alhajjat, Beverly S Strong, Amanda E Lee, Lucas E Turner, Ram K Wadhwani, John R Ortaldo, Jonathan W Heusel, Aimen F Shaaban

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Regenerative medicine: prenatal approaches.The Lancet. Child & adolescent health · 2022
    Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Amir M AlhajjatDepartment of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA 52242;
Beverly S StrongDepartment of Surgery, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH 45229;
Amanda E LeeDepartment of Surgery, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH 45229;
Lucas E TurnerDepartment of Surgery, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH 45229;
Ram K WadhwaniDepartment of Surgery, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH 45229;
John R OrtaldoExperimental Therapeutics Section, National Cancer Institute, Frederick, MD 21702;
Jonathan W HeuselDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110; and Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110.
Aimen F ShaabanDepartment of Surgery, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH 45229; aimen.shaaban@cchmc.org.ORCID http://orcid.org/0000-0002-9459-107X
Cincinnati Children's Hospital Medical Center · USNational Cancer Institute · USUniversity of Iowa · USWashington University in St. Louis · US

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
ROLE OF ANGPTL4, AN ANGIOGENIC MEDIATOR, IN ARTHRITISP30AR047363 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI FLICK, MATTHEW J. · 2001 to 2015
$9.2M
Cincinnati Center for Excellence in Molecular HematologyP30DK090971 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2010 to 2015
$4.0M
The NK cell response to prenatal allotransplantationR01HL103745 · NHLBI · UNIVERSITY OF IOWA · PI SHAABAN, AIMEN F · 2011 to 2015
$1.9M
MHC Class Ib Mismatch in Prenatal TransplantationR21AI069882 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SHAABAN, AIMEN F · 2006 to 2007
$398k
NHLBI NIH HHS R01 HL103745NHLBI NIH HHS R01HL103745NIAID NIH HHS R21 AI069882NIAMS NIH HHS AR47363NIAMS NIH HHS P30 AR047363NIDDK NIH HHS DK78392NIDDK NIH HHS DK90971NIDDK NIH HHS P30 DK078392NIDDK NIH HHS P30 DK090971
6 · The paper itself

Abstract

Little is known about how the prenatal interaction between NK cells and alloantigens shapes the developing NK cell repertoire toward tolerance or immunity. Specifically, the effect on NK cell education arising from developmental corecognition of alloantigens by activating and inhibitory receptors with shared specificity is uncharacterized. Using a murine prenatal transplantation model, we examined the manner in which this seemingly conflicting input affects NK cell licensing and repertoire formation in mixed hematopoietic chimeras. We found that prenatal NK cell tolerance arose from the elimination of phenotypically hostile NK cells that express an allospecific activating receptor without coexpressing any allospecific inhibitory receptors. Importantly, the checkpoint for the system appeared to occur centrally within the bone marrow during the final stage of NK cell maturation and hinged on the instructive recognition of allogeneic ligand by the activating receptor rather than through the inhibitory receptor as classically proposed. Residual nondeleted hostile NK cells expressing only the activating receptor exhibited an immature, anergic phenotype, but retained the capacity to upregulate inhibitory receptor expression in peripheral sites. However, the potential for this adaptive change to occur was lost in developmentally mature chimeras. Collectively, these findings illuminate the intrinsic process in which developmental allorecognition through the activating receptor regulates the emergence of durable NK cell tolerance and establishes a new paradigm to fundamentally guide future investigations of prenatal NK cell-allospecific education.

Indexed as

Immune ToleranceLymphocyte ActivationAdoptive TransferAnimalsBone Marrow TransplantationClonal AnergyGraft RejectionH-2 AntigensHomeostasisImmunophenotypingIsoantigensKiller Cells, NaturalMiceModels, AnimalPhenotypeReceptors, ImmunologicH-2 AntigensIsoantigensReceptors, Immunologic

Identifiers

PMID26136432
PMCPMC4574102
OpenAlexW2128491895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.